AI English summary of an SEC filing — figures as filed
The company said on January 29, 2024 it closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 under Form S-3 registration.
Key points
AI summaryThe company said on January 29, 2024 it closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 under Form S-3 registration.
The company also said it closed an underwritten public offering of $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 on the same day.
Procter & Gamble said the notes were issued under Registration Statement on Form S-3 (Registration No. 333-275071), and that the related legal opinions were attached as Exhibits 5(a) and 5(b).
The company said Exhibit 5(a) is the opinion of Jennifer Henkel, Esq., Director and Assistant General Counsel, and Exhibit 5(b) is the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP. It said the related consents were filed as Exhibits 23(a) and 23(b).
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
$600,000,000 offering of 4.350% Notes due January 29, 2029
The company said on January 29, 2024 it closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 under Form S-3 registration.
Source · Based on the filing body and exhibits
$750,000,000 offering of 4.550% Notes due January 29, 2034
The company also said it closed an underwritten public offering of $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 on the same day.
Source · Based on the filing body and exhibits
Registration Statement on Form S-3 and Legal Opinions
Procter & Gamble said the notes were issued under Registration Statement on Form S-3 (Registration No. 333-275071), and that the related legal opinions were attached as Exhibits 5(a) and 5(b).
Source · Based on the filing body and exhibits
Legal Opinion Authors and Consent Filings
The company said Exhibit 5(a) is the opinion of Jennifer Henkel, Esq., Director and Assistant General Counsel, and Exhibit 5(b) is the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP. It said the related consents were filed as Exhibits 23(a) and 23(b).
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…